Award notice observed
Latest variant observed by Bidwake on .
Open this official Contracts Finder notice
Record references
- Release reference
5ce17d64-f30a-47b5-916f-e45e3f31e0da-795000- Published tags
- award
Public procurement
See the published facts, notice history, awards and supplier links in one place. Open the original Contracts Finder notice for the full record.
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0Published facts
5ce17d64-f30a-47b5-916f-e45e3f31e0da-795000Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Observed notice trail
Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.
Award notice observed
Latest variant observed by Bidwake on .
Open this official Contracts Finder notice
5ce17d64-f30a-47b5-916f-e45e3f31e0da-795000Awards and suppliers
Buyer: NHS EnglandSupplier: AMAROX LIMITED
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: Accord-UK Ltd
End dates, recurrence wording and links are shown as they appear in public notices. They do not create a new opportunity. If no later linked record appears here, that means Bidwake did not find one in the records it has loaded; it does not prove that none exists.
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: CELIX PHARMA LTd
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: DR REDDY'S LABORATORIES (UK) LIMITED
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: GLENMARK PHARMACEUTICALS EUROPE LIMITED
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: Gilead Sciences Limited
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: MERCURY PHARMACEUTICALS LIMITED
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: Seacross Pharmaceuticals Ltd
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: TILLOMED LABORATORIES LIMITED
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: Teva UK Limited
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: Thornton and Ross Ltd
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1Buyer: NHS EnglandSupplier: ZENTIVA PHARMA UK LIMITED
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0-1